| ●Editorial | Nagai Y | 4-5 | Full text | |
| ●Translation | ||||
| Guidance for best practices for clinical trials | World Health Organization （Translation and supervise : Nagai Y） | 7-84 | Full text | |
| ●ISPOR Japan Chapter & Society for Health Data Science Joint Symposium | ||||
| Methods and Challenges in Developing Decision-Analytic Models for Health Economic Evaluation | 85-132 | Abstract | ||
| Organized by : International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Japan chapter Society for Health Data Science | ||||
| Lecture 1 | Teramukai S | 88-93 | ||
| Lecture 2 | Moriwaki K | 94-108 | ||
| Comment 1 | Daimon T | 109-12 | ||
| Comment 2 | Tanaka S | 113-8 | ||
| Comment 3 | Aranishi T | 119-23 | ||
| Panel discussion | 124-32 | |||
| Closing remarks | Kobayashi M | 132 | ||
| ●Current status and challenges in pharmaceutical medicine | ||||
| Introduction to the environment and recommendations for non-promotional activities in Medical Education involving pharmaceutical companies | Murakami H，Fujita A， Sato H |
133-40 | Abstract | |
| Research on career development and well-being of physicians and PhD researchers in the pharmaceutical industry | Omura J，Maeda-Chubachi T， Tamada H，et al． |
141-69 | Abstract | |
| ●Translation and explanatory article | ||||
| Reappraisal of vitamin D RDA: Synthesizing recent findings by Kodama et al. with Papadimitriou’s 2017 critical review |
Fukushima M | 171-2 | Full text | |
| Efficacy of vitamin D replacement therapy on 28 cases of myalgic encephalomyelitis/chronic fatigue syndrome after COVID-19 vaccination |
Kodama S，Konishi N， Hirai Y，et al． | 173-88 | Full text | |
| ●Discussions on vaccine safety | ||||
| Justification for the withdrawal of “Increased age-adjusted cancer mortality after the third mRNA-lipid nanoparticle vaccine dose during the COVID-19 pandemic in Japan” |
Suzuki S | 189-98 | Full text | |
| Request for correction regarding criticisms of the Nagoya Study by Shitara and Morikawa | Suzuki S | 199-202 | Abstract | |
| The Nagoya Study as an analytical epidemiological study: A response to the Kumamoto article based on the standard epidemiological approach | Suzuki S | 203-11 | Abstract | |
| ●Article | ||||
| Profanities in anatomy labs: A consideration around the unethical conducts of a Japanese cosmetic surgeon in a clinical anatomy practice | Saio T | 213-8 | Full text | |
| ●Instructions for authors［Japanese］＆［English］ | 219-27 | Full text | ||
| ●Editor’s note－Value of No-Go Decision | Watanabe H | 229 | Full text | |